Items tagged with Treatment
MSF calls on Johnson & Johnson to lower price of lifesaving TB drug (post with simple image)
Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.
Stop TB Partnership and Johnson & Johnson announce price reduction for bedaquiline (post with simple image)
Stop TB Partnership and Johnson & Johnson, with support from USAID and the Global Fund, announce price reduction for bedaquiline for treatment of drug-resistant TB in low- and middle-income countries.
Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment (post with simple image)
120,707 people signed petitions urging the corporation to drop the price.
Treatment Action Group statement on bedaquiline unaffordability (post with simple image)
Bedaquiline is a public good, and must be treated as such. Johnson & Johnson once again refused to meet evidence-based demands to price bedaquiline at $1/day.
TB CAB Statement (post with simple image)
TB CAB Access Considerations Statement Regarding Johnson & Johnson Announcement of Bedaquiline Price Reduction
Landmark TB trial identifies shorter-course treatment regimen (post with simple image)
Landmark phase III trial shows that the shorter regimen containing rifapentine and moxifloxacin can safely and effectively cure TB in four months.
SHINE trial on shorter treatment for children with minimal TB (post with simple image)
TB treatment can be shortened from six to four months in 80% of children.
First digital adherence technology in the GDF’s product catalog (post with simple image)
Smart medication container included in Stop TB Partnership's Global Drug Facility (GDF) product catalog.
TAG's 2020 Pipeline Report: TB chapters released (post with simple image)
Treatment Action Group (TAG) launches newly available TB chapters of its 2020 Pipeline Report.
Page 83 of 83 · Total posts: 0←First 82 83